Jeffrey B. Hargis
Expertise in
9
conditions

Dr. Jeffrey B. Hargis

Oncology
3991 Dutchmans Lane, Suite 405, 
Louisville, KY 
Accepting New Patients
Expertise in
9
conditions
3991 Dutchmans Lane, Suite 405, 
Louisville, KY 

Overview

Jeffrey Hargis is an Oncologist practicing medicine in Louisville, Kentucky.

Dr. Hargis is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Hargis is board certified in American Board Of Internal Medicine, Internal Medicine - 1987, American Board Of Internal Medicine, Medical Oncology - 1989 , and American Board Of Internal Medicine, Hematology - 1990 . He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 4 clinical trials. Dr. Hargis is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in OH

Board Certifications

American Board Of Internal Medicine, Internal Medicine - 1987
American Board Of Internal Medicine, Medical Oncology - 1989
American Board Of Internal Medicine, Hematology - 1990

Fellowships

Walter Reed Army Medical Center, Medical Oncology, 1990

Hospital Affiliations

Norton Hospitals, Inc
Baptist Health Lagrange
Norton Clark Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Norton Cancer Institute - St. Matthews
3991 Dutchmans Lane, Suite 405, Louisville, KY 40207

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug
Study Drugs: Tucatinib, Trastuzumab, Pertuzumab
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3
Phase 2 Study of the Safety, Efficacy, and Pharmacokinetics of G1T28 in Patients With Metastatic Triple Negative Breast Cancer Receiving Gemcitabine and Carboplatin Chemotherapy
Phase 2 Study of the Safety, Efficacy, and Pharmacokinetics of G1T28 in Patients With Metastatic Triple Negative Breast Cancer Receiving Gemcitabine and Carboplatin Chemotherapy
Enrollment Status: Terminated
Publish Date: March 23, 2022
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Carboplatin
Study Phase: Phase 2
View 3 Less Clinical Trials

1 Total Publications

A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application.
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application.
Journal: Breast cancer research and treatment
Published: October 09, 2020
Similar Doctors
Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Uofl Health James Graham Brown Cancer Center

529 S Jackson St, 
Louisville, KY 
 (6.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jason Chesney is an Oncologist practicing medicine in Louisville, Kentucky. Dr. Chesney is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Melanoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma. Dr. Chesney is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Norton Cancer Institute Brownsboro

4955 Norton Healthcare Blvd, 
Louisville, KY 
 (6.3 miles away)
502-394-6350
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients

Renato La Rocca is an Oncologist practicing medicine in Louisville, Kentucky. Dr. La Rocca is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Embryonal Tumor with Multilayered Rosettes, Neuroepithelioma, and Atypical Teratoid Rhabdoid Tumor (ATRT). Dr. La Rocca is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

University Of Louisville Physicians - Obstetrics And Gynecology - Women's Health

6420 Dutchmans Parkway, Suite 190, 
Louisville, KY 
 (0.6 miles away)
502-561-7220
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Metzinger is an Oncologist practicing medicine in Louisville, Kentucky. Dr. Metzinger is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Vulvar Cancer, Bladder Reconstruction, and Salpingo-Oophorectomy. Dr. Metzinger is board certified in American Board Of Obstetrics And Gynecology, Gynecologic Oncology - 2007 and American Board Of Obstetrics And Gynecology, Obstetrics And Gynecology - 2003. Dr. Metzinger is currently accepting new patients.

Frequently Asked Questions about Dr. Jeffrey B. Hargis

How do I make an appointment with Dr. Jeffrey B. Hargis?

You can book an appointment with Dr. Jeffrey B. Hargis by calling their office at 502-899-3366. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey B. Hargis a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey B. Hargis is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey B. Hargis specialize in?

While Dr. Jeffrey B. Hargis is a Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jeffrey B. Hargis participate in research or clinical trials?

Yes. Dr. Jeffrey B. Hargis has published 1 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Jeffrey B. Hargis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey B. Hargis accept my insurance?

Dr. Jeffrey B. Hargis accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 502-899-3366 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hargis's expertise for a condition
ConditionClose
    View All 58 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile